Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17309159 | 1.00 | ALDH1A1 (0.36) | ALDH1A1TDP1LMNAHSD17B10FFAR3 | |
| SCHEMBL23660530 | 0.81 | ALDH1A1 (0.37) | ALDH1A1FFAR3TSHR | |
| SCHEMBL3747090 | 0.81 | ALDH1A1 (0.37) | ALDH1A1FFAR3TSHR | |
| SCHEMBL3414645 | 0.80 | ALDH1A1 (0.36) | ALDH1A1TDP1LMNAHSD17B10FFAR3 | |
| SCHEMBL8952938 | 0.79 | ALDH1A1 (0.40) | ALDH1A1TDP1LMNAHSD17B10FFAR3 | |
| SCHEMBL8616866 | 0.78 | ALDH1A1 (0.35) | ALDH1A1TDP1LMNA | |
| SCHEMBL8789803 | 0.78 | LMNA (0.38) | ALDH1A1TDP1LMNAFFAR3TSHR | |
| SCHEMBL5280336 | 0.77 | ALDH1A1 (0.42) | ALDH1A1TDP1LMNAHSD17B10FFAR3 | |
| SCHEMBL8165949 | 0.77 | ALDH1A1 (0.42) | ALDH1A1TDP1LMNAHSD17B10FFAR3 | |
| SCHEMBL6915530 | 0.77 | ALDH1A1 (0.38) | ALDH1A1TDP1LMNAHSD17B10FFAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1151844-C | Preparation of pharmaceutical active granules | ����ڶ�-PPC�ɷ�����˾ | 2004-06-02 | — | — | CN | claimed |
| CN-1249950-A | Preparation of pharmaceutical active granules | MCNEIL PPC INC (US) | 2000-04-12 | — | — | CN | claimed |
| CN-110128655-A | One kind being based on mercaptan-alkene selfreparing photosensitive resin composition and application | 岭南师范学院 | 2019-08-16 | — | — | CN | disclosed |
| EP-3342825-A1 | METHOD FOR PRODUCING POLYMER POLYOL | Sanyo Chemical Industries, Ltd. (JP) | 2018-07-04 | — | — | EP | disclosed |
| EP-1316569-B1 | POLYMER POLYOL COMPOSITIONS, PROCESS FOR PRODUCING THE SAME, AND PROCESS FOR PRODUCING POLYURETHANE RESIN | SANYO CHEMICAL IND LTD (JP) | 2015-03-04 | — | — | EP | disclosed |
| EP-1978047-B1 | Polymer polyol composition, method for producing the same, and method for producing polyurethane resin | SANYO CHEMICAL IND LTD (JP) | 2015-03-04 | — | — | EP | disclosed |
| US-8455591-B2 | Fine particle-dispersed polyol composition, method for producing polymer polyol, and method for producing polyurethane resin | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2013-06-04 | — | — | US | disclosed |
| US-8394899-B2 | Fine particle-dispersed polyol composition, method for producing polymer polyol, and method for producing polyurethane resin | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2013-03-12 | — | — | US | disclosed |
| US-20100152209-A1 | Compounds for Modulating TRPV3 Function | HYDRA BIOSCIENCES INC. (US) | 2010-06-17 | — | — | US | disclosed |
| CN-101140433-B | Electrostatic image developing carrier, electrostatic image developing developer, electrostatic image developing developer cartridge, process cartridge, and image forming apparatus | FUJI XEROX CO LTD | 2010-06-02 | — | — | CN | disclosed |
| US-20100010162-A1 | ACTIVE ENERGY-RAY-CURABLE WATER- BASED RESIN COMPOSITION, ACTIVE ENERGY-RAY-CURABLE COATING MATERIAL, METHOD OF FORMING CURED COATING FILM, AND ARTICLE | DIC CORPORATION (JP) | 2010-01-14 | — | — | US | disclosed |
| US-20050245724-A1 | Process for production of polymer polyol, and polymer polyol | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2005-11-03 | — | — | US | disclosed |
| US-6756414-B2 | ETHYLENICALLY-UNSATURATED POLYMER DISPERSED IN A POLYOL; LOW VISCOSITY AND EXCELLENT DISPERSION STABILITY EVEN AT A HIGH CONCENTRATION OF PARTICLES; POLYURETHANE RESINS HAVING EXCELLENT HARDNESS AND COMPRESSION SET, FOAMS | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2004-06-29 | — | — | US | disclosed |
| CN-1151844-C | Preparation of pharmaceutical active granules | ����ڶ�-PPC�ɷ�����˾ | 2004-06-02 | — | — | CN | disclosed |
| US-20030216486-A1 | Polymer polyol composition, process for producing the same, and process for producing polyurethane resin | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2003-11-20 | — | — | US | disclosed |
| US-6624209-B2 | Block polymers | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2003-09-23 | — | — | US | disclosed |
| EP-1316569-A1 | POLYMER POLYOL COMPOSITIONS, PROCESS FOR PRODUCING THE SAME, AND PROCESS FOR PRODUCING POLYURETHANE RESIN | SANYO CHEMICAL INDUSTRIES, Ltd. (JP) | 2003-06-04 | — | — | EP | disclosed |
| US-20030004217-A1 | Polymer polyol composition, process for producing the same, and process for producing polyurethane resin | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2003-01-02 | — | — | US | disclosed |
| CN-1249950-A | Preparation of pharmaceutical active granules | MCNEIL PPC INC (US) | 2000-04-12 | — | — | CN | disclosed |
| CN-86106049-A | PHOTOCURING PAINT FOR ARTIFICIAL MARBLE DECORATIVE PLATE | — | 1987-08-26 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152209-A1 | Compounds for Modulating TRPV3 Function | TRPV3, TRPV1, TRPV4 | ALDH1A1 3074/4885TDP1 3853/4885LMNA 3054/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.